Bloomberg

In Bond-Market Irony, Inflation Is Lower Than When Fed Eased

by

The lack of wage growth has contributed to slower price gains.

Pimco’s Rate-Rise Bond Strategy: Buy Corporates Straddling Junk

by

Securities near the middle of the quality scale will probably be in a sweet spot when the Federal Reserve raises rates.

Pending Sales of Existing Homes In U.S. Drop by Most In A Year

by

Fewer available properties, higher prices and still-tight credit are hurdles for some customers as first-time buyers remain reluctant to enter the market.

Shrinking Bond Desks Populated By Journeymen As Masters Fade

by

As bond trading has declined, so have the jobs, leaving even some of the most senior traders and salesmen moving from firm to firm.

Individuals Pile Into Stocks Just As Pros Say Bull Is Spent

by

Individual investors are plowing money back into the U.S. stock market just as professional strategists say gains for this year are over.

Gilead CEO Martin Becomes Billionaire On $84,000 Liver Drug

by

John C. Martin, the CEO of Gilead Sciences, has become a billionaire on the prospects of a powerful new hepatitis C drug that’s attracting scrutiny over its $1,000 per pill price tag.